Christoph Westphal, Ten Percent Owner at Salarius Pharmaceuticals, holds 2.32M shares in TScan Therapeutics (Ticker: TCRX), holds 3.94M shares in Salarius Pharmaceuticals (Ticker: SLRX), holds 2.17M shares in Verastem (Ticker: VSTM). Most recently, Christoph Westphal Bought ― shares of TScan Therapeutics on Jul 22, 2021 for an estimated value of 2.00M.